New Developments in Tuberculosis Diagnosis and Treatment

Overview

Journal Breathe (Sheff)

Specialty Pulmonary Medicine

Date 2022 Mar 14

PMID 35284018

Authors

Cara M Gill

Lorraine Dolan

Laura M Piggott

Anne Marie McLaughlin

Affiliations

Soon will be listed here.

Abstract

Educational Aims: Differentiate between TB infection and TB disease.Understand the different methods of diagnosing TB disease and resistance.Recognise the different drugs and regimens currently in use for TB disease.Be able to discuss risk of TB disease in TB infection, and assist patients in making an informed decision on treatment for TB infection.

Citing Articles

One Health Approach to the Computational Design of a Lipoprotein-Based Multi-Epitope Vaccine Against Human and Livestock Tuberculosis.

Shey R, Nchanji G, Stong T, Yaah N, Shintouo C, Yengo B Int J Mol Sci. 2025; 26(4).

PMID: 40004053 PMC: 11855821. DOI: 10.3390/ijms26041587.

Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals.

Muriithi B, Bundi M, Moriyasu T, Ahmed A, Mwamzuka M, Karama M IJTLD Open. 2025; 2(1):26-32.

PMID: 39802227 PMC: 11724533. DOI: 10.5588/ijtldopen.24.0410.

Structural Characterization of Encapsulin in Complex with Dye-Decolorizing Peroxide.

Cuthbert B, Chen X, Burley K, Batot G, Contreras H, Dixon S Microorganisms. 2025; 12(12.

PMID: 39770668 PMC: 11676171. DOI: 10.3390/microorganisms12122465.

Model for predicting drug resistance based on the clinical profile of tuberculosis patients using machine learning techniques.

Falcao I, Cardoso D, Coutinho Dos Santos Santos A, Paixao E, Costa F, Figueiredo K PeerJ Comput Sci. 2024; 10:e2246.

PMID: 39650511 PMC: 11623081. DOI: 10.7717/peerj-cs.2246.

Why do healthcare workers refuse tuberculosis preventive treatment (TPT)? a qualitative study from Puducherry, South India.

Subramanian S, Gnanadhas J, Sarkar S, Rajaram M, Prakashbabu S, Chinnakali P BMJ Open Respir Res. 2024; 11(1.

PMID: 39645238 PMC: 11624695. DOI: 10.1136/bmjresp-2024-002576.

References

Selwyn P, Hartel D, Lewis V, Schoenbaum E, Vermund S, Klein R . A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989; 320(9):545-50. DOI: 10.1056/NEJM198903023200901. View

Law S, Daftary A, ODonnell M, Padayatchi N, Calzavara L, Menzies D . Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review. Eur Respir J. 2018; 53(1). DOI: 10.1183/13993003.01030-2018. View

Muller B, Streicher E, Hoek K, Tait M, Trollip A, Bosman M . inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa?. Int J Tuberc Lung Dis. 2011; 15(3):344-51. View

Harris M, Qi A, Jeagal L, Torabi N, Menzies D, Korobitsyn A . A systematic review of the diagnostic accuracy of artificial intelligence-based computer programs to analyze chest x-rays for pulmonary tuberculosis. PLoS One. 2019; 14(9):e0221339. PMC: 6719854. DOI: 10.1371/journal.pone.0221339. View

Zaw M, Emran N, Lin Z . Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018; 11(5):605-610. DOI: 10.1016/j.jiph.2018.04.005. View

Chaisson R, Ramchandani R, Swindells S . One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis. Reply. N Engl J Med. 2019; 381(11):e23. DOI: 10.1056/NEJMc1908492. View

Nabavinia M, Naderi Nasab M, Meshkat Z, Derakhshan M, Khaje-Karamadini M . Construction of an Expression Vector Containing Mtb72F of Mycobacterium tuberculosis. Cell J. 2013; 14(1):61-6. PMC: 3635822. View

Dorman S, Schumacher S, Alland D, Nabeta P, Armstrong D, King B . Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect Dis. 2017; 18(1):76-84. PMC: 6168783. DOI: 10.1016/S1473-3099(17)30691-6. View

Kleinnijenhuis J, Quintin J, Preijers F, Joosten L, Ifrim D, Saeed S . Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012; 109(43):17537-42. PMC: 3491454. DOI: 10.1073/pnas.1202870109. View

10.

Malenfant J, Brewer T . Rifampicin Mono-Resistant Tuberculosis-A Review of an Uncommon But Growing Challenge for Global Tuberculosis Control. Open Forum Infect Dis. 2021; 8(2):ofab018. PMC: 7888568. DOI: 10.1093/ofid/ofab018. View

11.

Somoskovi A, Dormandy J, Rivenburg J, Pedrosa M, McBride M, Salfinger M . Direct comparison of the genotype MTBC and genomic deletion assays in terms of ability to distinguish between members of the Mycobacterium tuberculosis complex in clinical isolates and in clinical specimens. J Clin Microbiol. 2008; 46(5):1854-7. PMC: 2395102. DOI: 10.1128/JCM.00105-07. View

12.

Nahid P, Mase S, Migliori G, Sotgiu G, Bothamley G, Brozek J . Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med. 2019; 200(10):e93-e142. PMC: 6857485. DOI: 10.1164/rccm.201909-1874ST. View

13.

Tortoli E, Cichero P, Piersimoni C, Simonetti M, Gesu G, Nista D . Use of BACTEC MGIT 960 for recovery of mycobacteria from clinical specimens: multicenter study. J Clin Microbiol. 1999; 37(11):3578-82. PMC: 85696. DOI: 10.1128/JCM.37.11.3578-3582.1999. View

14.

Steingart K, Schiller I, Horne D, Pai M, Boehme C, Dendukuri N . Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014; (1):CD009593. PMC: 4470349. DOI: 10.1002/14651858.CD009593.pub3. View

15.

Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P . Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015; 372(12):1181-2. DOI: 10.1056/NEJMc1413930. View

16.

Lee S . Tuberculosis Infection and Latent Tuberculosis. Tuberc Respir Dis (Seoul). 2016; 79(4):201-206. PMC: 5077723. DOI: 10.4046/trd.2016.79.4.201. View

17.

Tian J, Lu Z, Bachmann M, Song F . Effectiveness of directly observed treatment of tuberculosis: a systematic review of controlled studies. Int J Tuberc Lung Dis. 2014; 18(9):1092-8. DOI: 10.5588/ijtld.13.0867. View

18.

Prasad R, Gupta N, Banka A . Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management. Lung India. 2018; 35(1):78-81. PMC: 5760876. DOI: 10.4103/lungindia.lungindia_98_17. View

19.

Ottenhoff T . A Trial of M72/AS01E Vaccine to Prevent Tuberculosis. N Engl J Med. 2020; 382(16):1576-1577. DOI: 10.1056/NEJMc2001364. View

20.

Wallis R, Ginindza S, Beattie T, Arjun N, Likoti M, Edward V . Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial. Lancet Respir Med. 2021; 9(8):897-908. PMC: 8332197. DOI: 10.1016/S2213-2600(20)30448-3. View